These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16447133)

  • 1. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
    Tan L;
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.
    Klein JO; Myers MG
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The United States pediatric vaccine stockpile program.
    Lane KS; Chu SY; Santoli JM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing government-operated vaccine programs: an industry perspective.
    Paradiso PR
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S118-20. PubMed ID: 16447132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee.
    Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B;
    JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
    Pisano W
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
    Evans G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
    Rodewald LE; Orenstein WA; Mason DD; Cochi SL
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.
    Orenstein WA; Schaffner W
    Am J Med; 2008 Jul; 121(7 Suppl 2):S22-7. PubMed ID: 18589064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A response to strategy #2: streamlining the regulatory process.
    Glezen WP
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S141-4. PubMed ID: 16447137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stockpile levels for pediatric vaccines: how much is enough?
    Jacobson SH; Sewell EC; Proano RA; Jokela JA
    Vaccine; 2006 Apr; 24(17):3530-7. PubMed ID: 16522344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. U.S. vaccine supply falls seriously short.
    Cohen J
    Science; 2002 Mar; 295(5562):1998-2001. PubMed ID: 11896251
    [No Abstract]   [Full Text] [Related]  

  • 16. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005.
    Klein JO; Helms CM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages.
    Iwane MK; Singleton JA; Walton K; Coulen C; Wooten K
    J Public Health Manag Pract; 2007; 13(3):307-13. PubMed ID: 17435498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting the nation's health: ensuring a stable supply of influenza vaccine.
    Seiguer E
    Issue Brief (Commonw Fund); 2005 Jul; (832):1-14. PubMed ID: 16193600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey.
    McQuillan L; Daley MF; Stokley S; Crane LA; Beaty BL; Barrow J; Babbel C; Dickinson LM; Kempe A
    Pediatrics; 2009 Feb; 123(2):e186-92. PubMed ID: 19171569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a severe influenza vaccine shortage on primary care practice.
    Kempe A; Daley MF; Stokley S; Crane LA; Beaty BL; Barrow J; Babbel C; Dickinson LM; Steiner JF; Berman S
    Am J Prev Med; 2007 Dec; 33(6):486-91. PubMed ID: 18022065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.